Wealth Enhancement Advisory Services’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.4M Buy
108,160
+320
+0.3% +$21K 0.02% 586
2026
Q1
$1.16M Buy
107,840
+94,895
+733% +$1.53M ﹤0.01% 1705
2025
Q4
$267K Buy
12,945
+9,680
+296% +$188K ﹤0.01% 3016
2025
Q3
$86.5K Sell
3,265
-948
-23% -$35.8K ﹤0.01% 3355
2025
Q2
$256K Buy
4,213
+225
+6% +$18K ﹤0.01% 2774
2025
Q1
$432K Buy
3,988
+715
+22% +$62.2K ﹤0.01% 2158
2024
Q4
$155K Buy
+3,273
New +$198K ﹤0.01% 2737

Other funds holding AGL

Wealth Enhancement Advisory Services's AGL Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Agilon Health (AGL) stake by 0.3% in Q2 2026, buying an estimated $21K and bringing the position to 108,160 shares worth $12.4M. The position accounts for 0.02% of the portfolio, ranked #586.

Wealth Enhancement Advisory Services first reported a position in AGL in Q4 2024 and has held it in 7 quarters since. 10 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Wealth Enhancement Advisory Services held 108,160 shares of Agilon Health worth $12.4M as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 320 Agilon Health shares in Q2 2026, an estimated $21K.
  • Agilon Health made up 0.02% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #586 holding.
  • Wealth Enhancement Advisory Services first reported a position in Agilon Health in Q4 2024 and has held it in 7 quarters since.
  • 10 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.